AlphAIAlphAI — Financial news for AI agents
theglobeandmail.comSEP 162 min read$BRO

BRO Stock Declines 27.1% in a Year: What Should Investors Do Now?

Brown & Brown (BRO) shares fell 27.1% in the past year, underperforming the industry. Factors include soft organic growth, elevated costs, and acquisition debt. Analysts see a 12.2% upside to $76.69. The company projects 2026 EPS growth of 5.6% and revenue growth of 19.2%. Competitors AON, AJG, and WTW also declined. BRO trades at a discount with a forward P/E of 14.12x.

Original reporting
theglobeandmail.com
Published Sep 16, 2026, 4:52 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 16, 2026, 8:39 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
BRO Stock Declines 27.1% in a Year: What Should Investors Do Now? — source image
Source · theglobeandmail.com
Decision brief

The 30-second read

$BRONeutralLow
01

Why it matters

The piece is a recap of existing metrics and analyst estimates, offering limited actionable insight.

02

Market read

Provides a snapshot of BRO's current valuation and growth outlook; minimal impact on broader market.

03

What to watch

Potential upside from AI-driven efficiency gains and upcoming acquisition synergies not fully priced in.

Relevance 4/10Novelty 2/10Timing: none

Background

Brown & Brown (BRO) has underperformed its peers over the past year; Zacks provides valuation and target price analysis.

Company-level read

Ticker impact

$BRONeutralMedium confidence
Context

Article reviews BRO's 27.1% price decline, valuation discount, Zacks target and growth estimates, but provides no new corporate event.

Expected impact

Limited upside, likely range-bound unless new catalyst emerges.

Evidence & confidence

Analysis is based on existing data; no fresh news to drive price movement.

Market effects

Sector

Highlights broader pressure on insurance brokers; valuation discounts may affect peers.

Regional

U.S. insurance brokerage sector sees mixed performance; no immediate regional shift.

Global

Limited; article focuses on a single U.S. broker.

Counterpoint

What could challenge this read

Despite valuation discount, BRO's strong cash flow and AI investments could drive a rebound if debt is managed.

Key entities

  • Company
    Brown & Brown, Inc.

    U.S.-listed insurance broker (ticker BRO).

Read at source← All news

Related articles

SEP 16
$BROMedAI 8/10

Winners And Losers Of Q2: Baldwin Insurance Group (NASDAQ:BWIN) Vs The Rest Of The Insurance Brokers Stocks

Ryan Specialty beat estimates but fell 11.1% to $39.20. Brown & Brown (BRO) reported $1.68B revenue, up 30.4% YoY, missing estimates by 2.5%, and dropped 3.4% to $67.32. Arthur J. Gallagher (AJG) reported $4.00B revenue, up 24.3% YoY, missing estimates by 0.5%, and fell 3.3% to $248.05. Marsh (MRSH) reported $7.40B revenue, up 6.2% YoY, beating estimates by 1.8%, and dropped 1.2% to $179.91.

finance.yahoo.com2 min
JUL 28
$BROMed

Why Are Brown & Brown (BRO) Shares Soaring Today

Brown & Brown (NYSE: BRO) shares rose about 5% after the company reported Q2 results. Revenue increased 30.4% year over year to $1.68B, slightly below analysts’ $1.72B estimate. Adjusted EPS was $1.07, in line with expectations, driving investor focus on strong growth despite the revenue miss.

financialcontent.com4 min
JUL 28
$BROMed

Brown & Brown Q2 Earnings Call Highlights

Brown & Brown (NYSE:BRO) discussed Q2 results on its earnings call. CFO Andy Watts said Retail revenue rose 35.9% mainly from acquisitions, while Retail organic growth was pressured by a pharmacy consulting business and a litigation-related organic revenue adjustment. Specialty Distribution total revenue rose 28.1% on Accession, with EBITDAC margin down to 42.7%. BRO expects H2 Retail organic growth excluding contingents of 1.5% to 2.5% and Specialty 2% to 4%, and reaffirmed $30M-$40M integratio

yahoo.com7 min
JUL 27
$BROMedAI 8/10

Brown & Brown, Inc. announces second quarter 2026 results, including total revenues of $1.7 billion, an increase of 30.4%; Organic Revenue decrease of 0.7%; growth of Organic Revenue with Contingents

Brown & Brown, Inc. (NYSE:BRO) reported unaudited Q2 2026 results. Total revenues rose to $1.7 billion, up 30.4% year over year, while organic revenue fell 0.7%. Net income attributable to the company increased to $288 million, and diluted EPS was $0.84. For six months, revenues were $3.6 billion, up 33.0%.

thestarphoenix.com6 min
JUL 27
$BROMedAI 8/10

BROWN & BROWN, INC. (BRO): Results of Operations and Financial Condition

BROWN & BROWN, INC. (BRO) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 bro-ex99_1.htm EX-99.1 EX-99.1 Exhibit 99.1 Brown & Brown, Inc. announces second quarter 2026 results, including total revenues of $1.7 billion, an increase of 30.4%; Organic Revenue decrease of 0.7%; growth of Organic Revenue with Contingents of 0.7%; diluted net incom

SEC EDGAR 8-K6 min